Prothrombotic and vascular risk factors in NAION [2]

Ophthalmology

Volumn 107, Issue 12, 2000, Pages 2116-2117

  Egan, Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; GENE MUTATION; GENETIC RISK; HUMAN; ISCHEMIC OPTIC NEUROPATHY; LETTER; PRIORITY JOURNAL; STROKE; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

EID: 0033646794     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(00)00258-X     Document Type: Letter

References (5)

1. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy
2. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease
3. A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosis
4. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study
5. Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct